Inventor
Shane M. WALLS
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations40%
C07DHeterocyclic compounds40%
A61KPreparations for medical, dental or toiletry purposes13%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
PatentTitleYear
12,351,571Substituted quinoxaline compounds as inhibitors of FGFR tyrosine kinases202512,180,207Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kinases202411,964,988Fused heterocyclic compounds as RET kinase inhibitors202411,851,434Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors202311,648,243Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors202311,472,802Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to ARRAY BIOPHARMA INC (6)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARRAY BIOPHARMA INC | 6 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2025 |